Abstract
Objective
Some studies have been carried out to evaluate the association between SNP12 in estrogen receptor 1 and cryptorchidism, but the results remain inconsistent. We carried out a meta-analysis to explore the association between this polymorphism and cryptorchidism risk.
Methods
All eligible studies were searched in PubMed, Web of Science, Embase and Cochrane Library. Pooled odds ratios, with 95 % confidence intervals, were assessed for the association using fixed- and random-effects models.
Results
Overall, four case–control studies (363 cases, 415 controls) were included in the meta-analysis. No significant publication bias (P Begg = 0.308, P Egger = 0.288) was found. A allele of SNP12 in estrogen receptor 1 was protective factor to cryptorchidism in allele model, dominant genetic model and heterozygote comparison in Caucasians, but the result was turned out to be false positive by trial sequential analysis. However, A in allele model was risk factor to cryptorchidism in Asians (odds ratio 2.02, 95 % confidence interval 1.03–3.01, p = 0.946 for heterogeneity) and the result was turned out to be true positive by trial sequential analysis, even though there were merely two original studies.
Conclusions
The results of this meta-analysis suggest that A allele of SNP12 in estrogen receptor 1 may increase the risk of cryptorchidism in Asians. Meanwhile, further well-designed studies with large sample sizes are required to confirm the present findings, especially in Caucasians.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00383-016-3926-x/MediaObjects/383_2016_3926_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00383-016-3926-x/MediaObjects/383_2016_3926_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00383-016-3926-x/MediaObjects/383_2016_3926_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00383-016-3926-x/MediaObjects/383_2016_3926_Fig4_HTML.gif)
Similar content being viewed by others
References
Hutson JM, Hasthorpe S, Heyns CF (1997) Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr Rev 18:259–280
Sijstermans K, Hack WW, Meijer RW, van der Voort-Doedens LM (2008) The frequency of undescended testis from birth to adulthood: a review. Int J Androl 31:1–11
Virtanen HE, Bjerknes R, Cortes D et al (2007) Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr 96:611–616
Boisen KA, Kaleva M, Main KM et al (2004) Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363:1264–1269
Boisen KA, Kaleva M, Main KM et al (2004) High and increasing prevalence of cryptorchidism in Denmark. Ugeskr Laeger 166:4372–4375
Preiksa RT, Zilaitiene B, Matulevicius V et al (2005) Higher than expected prevalence of congenital cryptorchidism in Lithuania: a study of 1204 boys at birth and 1 year follow-up. Hum Reprod 20:1928–1932
Virtanen HE, Adamsson A (2012) Cryptorchidism and endocrine disrupting chemicals. Mol Cell Endocrinol 355:208–220
Svechnikov K, Stukenborg JB, Savchuck I, Söder O (2014) Similar causes of various reproductive disorders in early life. Asian J Androl 16:50–59
Vidaeff AC, Sever LE (2005) In utero exposure to environmental estrogens and male reproductive health: a systematic review of biological and epidemiologic evidence. Reprod Toxicol 20:5–20
Cederroth CR, Schaad O, Descombes P et al (2007) Estrogen receptor alpha is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism. Endocrinology 148:5507–5519
Chevalier N, Brucker-Davis F, Lahlou N et al (2015) A negative correlation between insulin-like peptide 3 and bisphenol A in human cord blood suggests an effect of endocrine disruptors on testicular descent during fetal development. Hum Reprod 30:447–453
McLachlan JA (2001) Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr Rev 22:319–341
Mizuno K, Kojima Y, Kurokawa S, Kamisawa H, Kohri K, Hayashi Y (2011) Altered expression and localization of estrogen receptors alpha and beta in the testes of a cryptorchid rat model. Urology 77:251.e1–251.e6
Kotula-Balak M, Gancarczyk M, Sadowska J, Bilinskai B (2005) The expression of aromatase, estrogen receptor alpha and estrogen receptor beta in mouse Leydig cells in vitro that derived from cryptorchid males. Eur J Histochem 49:59–62
Tremblay JJ, Robert NM, Laguë E (2009) Nuclear receptors, testosterone, and posttranslational modifications in human INSL3 promoter activity in testicular Leydig cells. Ann N Y Acad Sci 1160:205–212
Anand-Ivell R, Ivell R (2014) Insulin-like factor 3 as a monitor of endocrine disruption. Reproduction 147:R87–R95
Yoshida R, Fukami M, Sasagawa I, Hasegawa T, Kamatani N, Ogata T (2005) Association of cryptorchidism with a specific haplotype of the estrogen receptor alpha gene: implication for the susceptibility to estrogenic environmental endocrine disruptors. J Clin Endocrinol Metab 90:4716–4721
Galan JJ, Guarducci E, Nuti F et al (2007) Molecular analysis of estrogen receptor alpha gene AGATA haplotype and SNP12 in European populations: potential protective effect for cryptorchidism and lack of association with male infertility. Hum Reprod 22:444–449
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605
Wetterslev J, Thorlund K, Brok J, Gluud C (2009) Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol 9:86
Borm GF, Donders AR (2009) Updating meta-analyses leads to larger type I errors than publication bias. J Clin Epidemiol 62:825–830
Brok J, Thorlund K, Gluud C, Wetterslev J (2008) Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol 61:763–769
Tang KF, Zheng JZ, **ng JP (2011) Molecular analysis of SNP12 in estrogen receptor α gene in hypospadiac or cryptorchid patients from Northwestern China. Urol Int 87:359–362
Wang Y, Barthold J, Figueroa E et al (2008) Analysis of five single nucleotide polymorphisms in the ESR1 gene in cryptorchidism. Birth Defects Res A Clin Mol Teratol 82:482–485
Nef S, Shipman T, Parada LF (2000) A molecular basis for estrogen-induced cryptorchidism. Dev Biol 224:354–361
Emmen JM, McLuskey A, Adham IM et al (2000) Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology 141:846–849
Bay K, Main KM, Toppari J, Skakkebæk NE (2011) Testicular descent: INSL3, testosterone, genes and the intrauterine milieu. Nat Rev Urol 8:187–196
Wetterslev J, Thorlund K, Brok J, Gluud C (2008) Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61:64–75
Higgins JP, Whitehead A, Simmonds M (2011) Sequential methods for random-effects meta-analysis. Stat Med 30:903–921
Kulinskaya E, Wood J (2014) Trial sequential methods for meta-analysis. Res Synth Methods 5:212–220
Acknowledgments
This work was supported by Children’s Hospital of Chongqing Medical University Clinical Research Projects (Project No: lcyj2014-16).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Additional information
Changkai Deng and Rong Dai contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Deng, C., Dai, R., Li, X. et al. A allele of SNP12 in estrogen receptor 1 was a risk factor for cryptorchidism in Asians: a systematic review with meta-analysis and trial sequential analysis. Pediatr Surg Int 32, 981–987 (2016). https://doi.org/10.1007/s00383-016-3926-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-016-3926-x